Literature DB >> 14573833

Baseline survey of sexually transmitted infections in a cohort of female bar workers in Mbeya Region, Tanzania.

G Riedner1, M Rusizoka, O Hoffmann, F Nichombe, E Lyamuya, D Mmbando, L Maboko, P Hay, J Todd, R Hayes, M Hoelscher, H Grosskurth.   

Abstract

OBJECTIVES: To determine baseline prevalence of sexually transmitted infections (STI) and other reproductive tract infections (RTI) and their association with HIV as well as sociodemographic and behavioural characteristics in a newly recruited cohort of female bar workers in Mbeya Region, Tanzania.
METHODS: 600 female bar workers were recruited from 17 different communities during September to November 2000 and underwent gynaecological examination, laboratory testing for HIV/STI, and interviews using structured questionnaires.
RESULTS: HIV-1 seroprevalence was 68%. Prevalences of STI/RTI were high titre syphilis (TPPA/RPR >/=1/8), 9%; herpes simplex virus 2 antibodies, 87%; chlamydia, 12%; gonorrhoea, 22%; trichomoniasis, 24%; and bacterial vaginosis, 40%. HIV infection was associated with TPPA and HSV-2 seropositivity, bacterial vaginosis and clinically diagnosed genital ulcers, blisters, and warts. Reported high risk sexual behaviour during the past year (having multiple casual partners) was associated with prevalent STI.
CONCLUSION: Female bar workers in Mbeya are at high risk of STI and HIV infection. Targeted STI/HIV prevention interventions for these women and their sexual partners need to be reinforced. Methods should be sought to improve healthcare seeking and to provide easily accessible and affordable STI care services.

Entities:  

Mesh:

Year:  2003        PMID: 14573833      PMCID: PMC1744739          DOI: 10.1136/sti.79.5.382

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  19 in total

1.  Evidence of declining STD prevalence in a South African mining community following a core-group intervention.

Authors:  R Steen; B Vuylsteke; T DeCoito; S Ralepeli; G Fehler; J Conley; L Bruckers; G Dallabetta; R Ballard
Journal:  Sex Transm Dis       Date:  2000-01       Impact factor: 2.830

2.  Sexually transmitted diseases in prostitutes in Moshi and Arusha, Northern Tanzania.

Authors:  W M Nkya; S H Gillespie; W Howlett; J Elford; C Nyamuryekunge; C Assenga; B Nyombi
Journal:  Int J STD AIDS       Date:  1991 Nov-Dec       Impact factor: 1.359

3.  Bridge populations in the spread of HIV/AIDS in Thailand.

Authors:  M Morris; C Podhisita; M J Wawer; M S Handcock
Journal:  AIDS       Date:  1996-09       Impact factor: 4.177

4.  Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2 from genital ulcers.

Authors:  K A Orle; C A Gates; D H Martin; B A Body; J B Weiss
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

5.  Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea.

Authors:  H Ghebrekidan; U Rudén; S Cox; B Wahren; M Grandien
Journal:  J Clin Virol       Date:  1999-01       Impact factor: 3.168

6.  Interrelationships of bacterial vaginosis and cervical inflammation.

Authors:  Jane R Schwebke; Heidi L Weiss
Journal:  Sex Transm Dis       Date:  2002-01       Impact factor: 2.830

7.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

8.  Genital ulcers associated with human immunodeficiency virus-related immunosuppression in female sex workers in Abidjan, Ivory Coast.

Authors:  P D Ghys; M O Diallo; V Ettiègne-Traoré; K M Yeboué; E Gnaoré; F Lorougnon; K Kalé; E Van Dyck; K Brettegaard; Y M Hoyi
Journal:  J Infect Dis       Date:  1995-11       Impact factor: 5.226

9.  Role of core and bridging groups in the transmission dynamics of HIV and STIs in Cotonou, Benin, West Africa.

Authors:  C M Lowndes; M Alary; H Meda; C A B Gnintoungbé; L Mukenge-Tshibaka; C Adjovi; A Buvé; L Morison; M Laourou; L Kanhonou; S Anagonou
Journal:  Sex Transm Infect       Date:  2002-04       Impact factor: 3.519

10.  Prevalence of bacterial vaginosis and its association with genital infections, inflammation, and contraceptive methods in women attending sexually transmitted disease and primary health clinics.

Authors:  H Moi
Journal:  Int J STD AIDS       Date:  1990-03       Impact factor: 1.359

View more
  40 in total

1.  Differences in HIV type 1 neutralization breadth in 2 geographically distinct cohorts in Africa.

Authors:  Gama P Bandawe; Penny L Moore; Lise Werner; Elin S Gray; Daniel J Sheward; Maphuti Madiga; Andile Nofemela; Ruwayhida Thebus; Jinny C Marais; Leonard Maboko; Salim S Abdool Karim; Michael Hoelscher; Lynn Morris; Carolyn Williamson
Journal:  J Infect Dis       Date:  2014-11-14       Impact factor: 5.226

Review 2.  Comparison of Diagnostic Accuracy of PCR Targeting the 47-Kilodalton Protein Membrane Gene of Treponema pallidum and PCR Targeting the DNA Polymerase I Gene: Systematic Review and Meta-analysis.

Authors:  Angèle Gayet-Ageron; Christophe Combescure; Stephan Lautenschlager; Béatrice Ninet; Thomas V Perneger
Journal:  J Clin Microbiol       Date:  2015-08-26       Impact factor: 5.948

3.  Mycoplasma genitalium: an organism commonly associated with cervicitis among west African sex workers.

Authors:  J Pépin; A-C Labbé; N Khonde; S Deslandes; M Alary; A Dzokoto; C Asamoah-Adu; H Méda; E Frost
Journal:  Sex Transm Infect       Date:  2005-02       Impact factor: 3.519

Review 4.  Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies.

Authors:  Julius Atashili; Charles Poole; Peter M Ndumbe; Adaora A Adimora; Jennifer S Smith
Journal:  AIDS       Date:  2008-07-31       Impact factor: 4.177

5.  Minor viral and host genetic polymorphisms can dramatically impact the biologic outcome of an epitope-specific CD8 T-cell response.

Authors:  Christof Geldmacher; Ian S Metzler; Sodsai Tovanabutra; Tedi E Asher; Emma Gostick; David R Ambrozak; Constantinos Petrovas; Alexandra Schuetz; Njabulo Ngwenyama; Gustavo Kijak; Leonard Maboko; Michael Hoelscher; Francine McCutchan; David A Price; Daniel C Douek; Richard A Koup
Journal:  Blood       Date:  2009-06-19       Impact factor: 22.113

6.  Concordance Between Laboratory Diagnosed Sexually Transmitted Infections and Self-Reported Measures of Risky Sex by Partner Type Among Rural Ugandan Outpatients.

Authors:  Susan M Kiene; Haruna Lule; Peter Hughes; Rhoda K Wanyenze
Journal:  AIDS Behav       Date:  2017-07

7.  Genital tract infections among HIV-infected pregnant women in Malawi, Tanzania and Zambia.

Authors:  S Aboud; G Msamanga; J S Read; A Mwatha; Y Q Chen; D Potter; M Valentine; U Sharma; I Hoffmann; T E Taha; R L Goldenberg; W W Fawzi
Journal:  Int J STD AIDS       Date:  2008-12       Impact factor: 1.359

8.  Are women who work in bars, guesthouses and similar facilities a suitable study population for vaginal microbicide trials in Africa?

Authors:  Andrew Vallely; Ian R Hambleton; Stella Kasindi; Louise Knight; Suzanna C Francis; Tobias Chirwa; Dean Everett; Charles Shagi; Claire Cook; Celia Barberousse; Deborah Watson-Jones; John Changalucha; David Ross; Richard J Hayes
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

9.  Sustained high prevalence of sexually transmitted infections among female sex workers in Cambodia: high turnover seriously challenges the 100% Condom Use Programme.

Authors:  Heng Sopheab; Guy Morineau; Joyce J Neal; Vonthanak Saphonn; Knut Fylkesnes
Journal:  BMC Infect Dis       Date:  2008-12-12       Impact factor: 3.090

10.  Microbicides development programme: engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania.

Authors:  Andrew Vallely; Charles Shagi; Shelley Lees; Katherine Shapiro; Joseph Masanja; Lawi Nikolau; Johari Kazimoto; Selephina Soteli; Claire Moffat; John Changalucha; Sheena McCormack; Richard J Hayes
Journal:  BMC Med Ethics       Date:  2009-10-09       Impact factor: 2.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.